QMS Medicosmetics GmbH

Smith & Williamson Corporate Finance advises QMS Medicosmetics GmbH (“QMS”) on its sale to BlueGem Capital Partners LLP (“BlueGem”)

Gettyimages 697853664 WEB
Published: 20 Oct 2017 Updated: 13 Apr 2022

Smith & Williamson Corporate Finance advises QMS Medicosmetics GmbH (“QMS”) on its sale to BlueGem Capital Partners LLP (“BlueGem”)

QMS is a leading premium skin care brand, founded in 1986 by the renowned German former facial surgeon Dr. med Erich Schulte. Over the years, Dr. Schulte has formulated a range of 35 scientifically advanced, high performance products, which are appreciated around the world for their efficacy. QMS is almost exclusively available in the spa channel, with in-house developed treatments as well as retail products. There are over 700 QMS locations worldwide, including some of the world’s best hotels, as well as Liberty in London and KaDeWe in Berlin.

The transaction was led by Jim Clark, Director at Smith & Williamson Corporate Finance, assisted by Zach Francis.

Dr Erich Schulte, founder of QMS said “We are a family owned business and this process was completely new to us. Jim and the team at Smith & Williamson gave considered and thoughtful advice and were always on hand to guide us through the process. Their commitment and experience ensured the transaction ran smoothly through to completion.

Emilio Di Spiezio Sardo, Partner of BlueGem said “We are delighted to have acquired QMS and are excited to work alongside Dr Schulte to take the Company through its next stage of growth and development. Jim and his team showed professionalism and integrity throughout the process.”
Jim Clark said “We are delighted to have assisted the shareholders on the sale of QMS to BlueGem. QMS is a highly regarded brand with huge potential for international growth under BlueGem’s ownership.

2017 has been a positive year for Smith & Williamson Corporate Finance, having completed transactions with an aggregate value in excess of US$1 billion in 2017 year to date across a range of sectors including branded consumer goods, technology, financial services, real estate, infrastructure, transport and energy.”
For further information please contact:

Jim Clark
T: 020 7131 4464
E: jim.clark@smithandwilliamson.com

By necessity, this briefing can only provide a short overview and it is essential to seek professional advice before applying the contents of this article. No responsibility can be taken for any loss arising from action taken or refrained from on the basis of this publication. Details correct at time of writing.

Note to editors
Smith & Williamson is an independently owned professional and financial services group with over 1,700 people. The group is a leading provider of investment management, financial advisory and accountancy services to private clients, professional practices and mid-to-large corporates. The group has eleven offices; these are in London, Belfast, Birmingham, Bristol, Dublin (City and Sandyford), Glasgow, Guildford, Jersey, Salisbury and Southampton.

Smith & Williamson Corporate Finance Limited
Authorised and regulated by the Financial Conduct Authority. A member of Oaklins International Inc. For legal notices, please refer www.oaklins.com/legal.


This article was previously published on Smith & Williamson prior to the launch of Evelyn Partners.